Trial Profile
A study investigating the effect of Sativex as an alternative treatment option to intrathecal baclofen in severe multiple sclerosis-related spasticity patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- 07 Dec 2015 New trial record